Princess Private Equity (PEY) Share Price, News & Analysis

Company Overview

Princess Private Equity Holding Limited specializes in private equity and debt investments in non-public companies or assets through privately negotiated transactions. The fund invests in primary and secondary fund investments, direct investments, and listed private equity. It makes private equity investments in buyout, venture capital, and special situation and private debt investments in mezzanine, second lien, or senior debt investments. The fund makes investments without limitations as to geographic regions, financing stage, vintage year, and industry. It also makes investments as limited partnerships in the form of private equity and private debt funds in the form of common and preferred equity, convertible securities, subordinated debt and warrants, or other derivatives.

Key Stats

• Today's Range: 10.15 to 10.20
• 50-Day Range: 10.15 to 10.95
• 52-Week Range: 9.94 to 11.85
• Volume: 17,891 shs
• Average Volume: 50,607 shs
• Market Capitalization: £7.02 million
• P/E Ratio: 37.60
• Dividend Yield: 709.15%
• Price Target: N/A
• Consensus Rating: N/A

PEY Stock Analysis - Frequently Asked Questions

How have PEY shares performed this year?

Princess Private Equity's stock was trading at GBX 10.70 on January 1st, 2025. Since then, PEY stock has decreased by 5.1% and is now trading at GBX 10.15.
View the best growth stocks for 2025 here.

How do I buy shares of Princess Private Equity?

Shares of PEY stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Princess Private Equity own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Princess Private Equity investors own include G1 Therapeutics (GTHX), M&G (MNG), Newmont (NEM), Viking Therapeutics (VKTX), Aew Uk Reit (AEWU), Aeva Technologies (AEVA) and AerCap (AER).

Company Calendar

• Ex-Dividend for 12/13 Dividend: 11/07/2024
• Dividend Payable: 12/13/2024
• Today: 1/21/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: N/A
• Current Symbol: LON:PEY
• CUSIP: N/A
• CIK: N/A
• Web: www.princess-privateequity.net
• Phone: +44-1481-730946
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX 0.27
• Trailing P/E Ratio: 37.78
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £18.42 million
• Net Margins: 31.72%
• Pretax Margin: N/A
• Return on Equity: 1.85%
• Return on Assets: 1.72%

Debt

• Debt-to-Equity Ratio: 1.94
• Current Ratio: 0.22
• Quick Ratio: 0.92

Sales & Book Value

• Annual Sales: £58.07 million
• Price / Sales: 0.12
• Cash Flow: GBX 68.73 per share
• Price / Cash Flow: 0.15
• Book Value: GBX 1,416 per share
• Price / Book: 0.01

Miscellaneous

• Outstanding Shares: 69,150,000
• Free Float: N/A
• Market Cap: £7.05 million
• Optionable: Not Optionable
• Beta: 0.44